Skip to content

Clinical trials

Phase 3 Lymphoma trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 3 Country / region: Czechia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20091
20101
20112
20121
20132
20151
20202
20212
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting7
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Bristol-Myers Squibb2
Genmab2
Loxo Oncology, Inc.2
Seagen Inc.2
ADC Therapeutics S.A.1
Acerta Pharma BV1
Celgene1
EBMT Solid Tumors Working Party1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma22
Lymphoma, Non-Hodgkin9
Lymphoma, Large B-Cell, Diffuse8
Lymphoma, B-Cell5
Lymphoma, Follicular5
Hematologic Diseases4
Hodgkin Disease4
Neoplasms3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Leukemia2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.